SLC1A5 and hepatocellular carcinoma: Given the enhanced expression of ASCT2 and LAT1 in HCC, the studies presented here were designed to assess the therapeutic potential of targeting each transporter, and to determine whether primary (epithelial) or metastatic (mesenchymal) phenotype human HCC cells are differentially reliant on these transporters for growth and viability.